Gastric Neoplasms: Clinical Trials

2 trials for Gastric Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow Gastric Neoplasms: new trials by email Literature Review of Gastric Neoplasms trials Research Report on Gastric Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
vvDD-hIL-2-RG-1 - Gastric Neoplasms, Esophageal Cancer
Phase 1RecruitingAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)182025-05-062025-06-03
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
ASG-5ME - Gastric Neoplasms, Pancreatic Neoplasms
Phase 1CompletedSeagen Inc.512010-07-012013-08-27

Narrower conditions

Stomach Neoplasms (2)  ·  Esophageal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Vaccinia (1)

Broader conditions

Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Stomach Diseases (2)  ·  DNA Virus Infections (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  Pancreatic Diseases (1)

Interventions

ASG-5ME (1)

Sponsors

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1)  ·  Seagen Inc. (1)

Countries

United States (2)

Top investigators

Nancy Whiting, PharmD, BCOP (1)  ·  Patrick Wagner, MD (1)